Skip to content

aTyr Pharma ATYR Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Returns
Return on equity-105.3%+2.5pp-107.8%-4.6pp-103.2%-18.0pp-85.2%-5.7pp-79.5%+0.2pp
Return on assets-79.2%-1.1pp-78.1%-2.3pp-75.8%-11.5pp-64.2%-4.0pp-60.3%-1.4pp
Return on invested capital-105.9%+3.3pp-109.2%-7.7pp-101.5%-13.9pp-87.5%-8.9pp-78.6%+8.0pp
Liquidity
Current ratio5.8×+0.5×5.3×-0.6×5.9×+0.3×5.6×-2.2×7.8×+2.3×
Quick ratio5.8×+0.5×5.3×-0.6×5.9×+0.3×5.6×-2.2×7.8×+2.3×
Cash ratio0.9×+0.1×0.7×+0.3×0.4×-0.7×1.1×+0.1×+0.2×
Leverage
Debt-to-equity0.2×0.0×0.2×0.0×0.2×0.0×0.2×0.0×0.2×0.0×
Debt-to-assets0.2×0.0×0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×
Per Share
Book value per share$0.59-18.6%$0.73-12.1%$0.83-0.6%$0.83-4.3%$0.87-8.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do aTyr Pharma's ratios come from?
Every ratio is computed from aTyr Pharma's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.